Gwo Xi Stem Cell Applied Technology
TWD20.80
0
+TWD0.05+0.24% 06:30 Today
Statistics
Day High
20.8
Day Low
19.5
52W High
28.9
52W Low
18
Volume
46,447
Avg. Volume
113,974
Mkt Cap
2B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-43.05%Profit Margin
Unprofitable187.02MRevenue
-80.52MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Show More
CEO
Chuan-Feng Chiu
Employees
55
Country
Taiwan
ISIN
TW0006704000
Listings
0 Comments
Share your thoughts
FAQs
What is Gwo Xi Stem Cell Applied Technology stock price today?▼
The current price of 6704.TWO is TWD20.80 TWD — it has increased by +0.24% in the past 24 hours. Watch Gwo Xi Stem Cell Applied Technology stock price performance more closely on the chart.
What is Gwo Xi Stem Cell Applied Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Gwo Xi Stem Cell Applied Technology stocks are traded under the ticker 6704.TWO.
Is Gwo Xi Stem Cell Applied Technology stock price growing?▼
6704.TWO stock has fallen by -7.14% compared to the previous week, the month change is a -15.79% fall, over the last year Gwo Xi Stem Cell Applied Technology has showed a -22.96% decrease.
What is Gwo Xi Stem Cell Applied Technology market cap?▼
Today Gwo Xi Stem Cell Applied Technology has the market capitalization of 2B
What is Gwo Xi Stem Cell Applied Technology revenue for the last year?▼
Gwo Xi Stem Cell Applied Technology revenue for the last year amounts to 187.02M TWD.
What is Gwo Xi Stem Cell Applied Technology net income for the last year?▼
6704.TWO net income for the last year is -80.52M TWD.
How many employees does Gwo Xi Stem Cell Applied Technology have?▼
As of November 3, 2026, the company has 55 employees.
In which sector is Gwo Xi Stem Cell Applied Technology located?▼
Gwo Xi Stem Cell Applied Technology operates in the Health & Wellness sector.
When did Gwo Xi Stem Cell Applied Technology complete a stock split?▼
Gwo Xi Stem Cell Applied Technology has not had any recent stock splits.
Where is Gwo Xi Stem Cell Applied Technology headquartered?▼
Gwo Xi Stem Cell Applied Technology is headquartered in Zhubei, Taiwan.